In this issue:
TSANZ position statement on CSLD and bronchiectasis
Defining long COVID
QoL with cemiplimab plus chemotherapy for advanced NSCLC
Impact of dysfunctional breathing on asthma control
Sixty-day dispensing of PBS medicines
PBS listings
PBAC recommendation regarding fluticasone propionate
Strict regulations and enforcement measures for all e-cigarettes
National lung screening program announced
COVID-19: A roadmap for recovery
Guideline for managing severe community-acquired pneumonia
Impact of treatable traits on asthma control and QoL
COVID-19 resources
Conferences, workshops and CPD
Please login below to download this issue (PDF)